Skip to main content
Premium Trial:

Request an Annual Quote

Michael Murphy, Sandra Foster, Michael Reinemann

Akonni Biosystems has appointed Michael Murphy as VP of regulatory affairs, Sandra Foster as director of quality assurance, and Michael Reinemann as director of business development. Murphy joins Akonni from Conatus Consulting, a regulatory consulting practice, where he served as president for seven years. He has also held executive management positions at ParagonDx, PPGx, Clingenix, and Gentris. Foster joins Akonni from her own private consulting company, Triangle GxP Solutions. She has also spent 12 years in various clinical-phase biotechnology companies. Reinemann joins Akonni from Qiagen, where he held various commercial operations roles, including regional marketing manager of North America and senior global product manager.

The Scan

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.

New Oral Nanomedicine Strategy Targets Gut-Brain Axis to Treat IBD

A new paper in Science Advances describes a platform to design polyphenol-armored oral medicines that are effective at treating inflammatory bowel disease.

Phylogenetic Data Enables New Floristic Map

Researchers in Nature Communications use angiosperm phylogenetic data to refine the floristic regions of the world.

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.